Discoveries That Curb Spread Of Antibiotic Resistance To Boost The Growth Of Antibiotics Market

Posted on: Jan-2019 | By: QY Research | Medical Devices

The rising use of antibiotics owing to high prevalence of severe infections, the elevated capital allotment for Research & Development activities by biotechnology firms, along with the supportive rules and standards have propelled the growth of the antibiotics market. Furthermore, the breakthrough of innovative combination therapies and advanced prospect molecules for treating antibiotic-resistant microbial infections would bring up opportunities for the players in the market in the coming period. Development of antibiotic resistance has been one of the challenges hampering market growth. However, below mentioned are few discovering that may lead to a potential solution in the future.

As we known, gleaming surfaces within hospitals can cover bacteria that hardly ever cause issues for healthy individuals, however, pose a severe danger to individuals with compromised immune systems. One such is Acinetobacter baumannii that results in severe bloodstream and lung infections in the hospitalized individuals. Such infections are one of the most intricate to treat as these bacteria have adapted to resist most antibiotics.

Now, scientists from Washington University School of Medicine in St. Louis have deciphered a major step in the transference of antibiotic resistance from one to another bacterium, a discovery that illuminates how antibiotic resistance disperses through a community or hospital.

The discovery opens up a novel approach to uphold our capability of treating bacterial infections by means of antibiotics. The study signifies that the effectiveness of existing antibiotics might be, to some extent, conserved by curbing the dispersion of antibiotic-resistance genes.

Likewise, the gene-editing tool CRISPR has been repurposed by a researcher from the University of Wisconsin-Madison together with his associates at the University of California, San Francisco, to examine which genes are aimed by specific antibiotics, offering hints on how to enhance prevailing antibiotics or make new ones. The method, called Mobile-CRISPRi, enables researchers to analyze antibiotic function in a broad array of pathogenic bacteria.

Thus, such findings and discoveries are likely to pave way for future developments and boost the growth of the antibiotics market.